While the COVID-19 vaccines introduced many people to RNA-based medicines, RNA oligonucleotides have already been on the market for years to treat diseases like Duchenne Muscular Dystrophy and ...

A newly developed mouse model enables real-time visualization of RNA Polymerase II (RNAP2) during DNA transcription, as ...

The remarkably preserved mammoth has pushed the known limits of RNA survival, offering rare insights into the real-time ...

RNA-based therapeutics are transforming medicine, but scaling production efficiently remains a challenge, particularly the ...

Showcases Scalable, Sustainable Enzymatic RNA Synthesis Platform as well as an Independent Cost Analysis at Industry’s Leading Oligonucleotide Conference WATERTOWN, Mass.--(BUSINESS WIRE)--EnPlusOne ...

WATERTOWN, Mass.--(BUSINESS WIRE)--EnPlusOne Biosciences, Inc., a biotechnology company harnessing the power of enzymes to deliver better RNA at scale, revealed today that it had achieved the ...

Within each cell, there is a constant struggle between life-sustaining molecules and molecules that could hasten its demise.

As a full-stack Gene Factory, Tsingke Biotech demonstrated capabilities spanning DNA/RNA synthesis, antibody expression, and nucleic acid process development. Its integrated platform connects ...

tRNAs have a distinct cloverleaf secondary structure and an L-shaped tertiary structure. The cloverleaf structure is formed by the folding of the single-stranded tRNA molecule, which is typically ...

Inside every cell, a finely tuned metabolic network determines when to build, recycle, or stop producing essential molecules.